Oncology & Cancer

Study finds increased cancer risk with bone growth product

Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted with the product, according to a new ...

Other

Study evaluates industry payments to orthopedic surgeons

An analysis of financial payments made by orthopedic device manufacturers to orthopedic surgeons shows that the patterns of payments from 2007 to 2010 appear to be complex with a reduction in the total number of payments ...

Cardiology

New study shows patients with coronary artery disease

Thrombotic (clotting) and bleeding events are complications that may occur after surgery. With the aging population in the western world, there are more patients undergoing orthopedic surgery than ever before. This makes ...

Other

Common spinal fusion product shown to be harmful

(Medical Xpress) -- The risk of complications associated with a bone growth factor commonly used in spinal fusion surgeries is estimated to be at least 10 to 50 times greater than previously reported in industry-sponsored ...

page 28 from 32